News

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
The dataset was created with help from 262 doctors who have worked in 60 countries. HealthDay News — OpenAI has unveiled a large dataset to help test how well artificial intelligence (AI) models ...
Fresh & Ready Foods has voluntarily recalled products with “use by” dates from April 22 to May 19, 2025, CNN said. The items were sold under the brand names Fresh & Ready Foods, City Point Market ...
Despite the approval of second-generation antiobesity medications, metabolic and bariatric surgery use among adolescents increased.
Glucagon-like peptide-1 receptor agonists are linked to a reduction in alcohol intake. HealthDay News — Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are tied to a reduction in alcohol intake, ...
Children with DKA had an increased likelihood of positive celiac serologies, and those with positive tTG-IgA had higher HbA1c concentrations.
Data from a phase 3 study indicated the microbiota-based live biotherapeutic RBL was safe and efficacious for recurrent CDI prevention in immunocompromised patients.
For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities persist.
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
President Donald Trump has chosen Dr Casey Means, a wellness influencer and health tech entrepreneur, to be his nominee for surgeon general.